A critical breakthrough in cancer study is occurring with the use of mini-antibodies to reactivate dysfunctional p53. This essential cancer protector protein is frequently inactivated in various forms of malignancies, https://bookmarklinx.com/story22007797/vhh-fragments-reactivate-the-p53-protein-the-promising-hope-for-tumor-management